BCL11B is a zinc finger transcription factor up-regulated by the oncogenic fusion protein EWS/FLI, creating a constitutively active transcription factor that is present in 85% of all Ewing sarcomas (Bailly et al, 1994). This evidence concerns the gene BCL11B and Ewing sarcoma.